Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2024-01-16 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
关于变更2023年度财务报表及内部控制审计报告签字注册会计师的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the change of the signing certified public accountants for the 2023 annual financial statements and internal control audit report of the company. It details the replacement of one auditor with another and confirms the independence and integrity of the new auditor. The document does not contain the audit report itself, nor does it include financial data or audit results. It is a regulatory announcement about auditor changes related to the audit report, not the audit report itself. Given the short length (1345 characters) and the nature of the content, this fits the category of Audit Report / Information (AR), which covers standalone audit reports and related audit information excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2023
2024-01-16 Chinese
八届董事会2024年第一次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the first interim meeting of the eighth board of directors in 2024 for the company. It details the election of the chairman and committee members of the board, including the voting results and the biography of the newly elected chairman. There are no financial statements, no discussion of financial performance, no audit information, and no mention of shareholder voting results at a general meeting. The content focuses on board and management changes, specifically the election of a new chairman and committee members. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS. Confidence is high due to clear content about board elections and management appointments.
2024-01-08 Chinese
2024年第一次临时股东会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of the 2024 first extraordinary general meeting (临时股东大会) of COFCO Biotechnology Co., Ltd. It details the legality and compliance of the meeting process, attendees' qualifications, and voting outcomes. The document does not contain financial statements or performance data but focuses on the official results and validation of shareholder votes at the meeting. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA). The document length is under 5,000 characters and is a formal legal opinion on the voting results, not a report or announcement of a report publication. Therefore, the correct classification is DVA with high confidence.
2024-01-02 Chinese
2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the company's 2024 first extraordinary general meeting of shareholders. It details the meeting date, attendance, voting results on specific proposals, and includes a legal opinion confirming the validity of the meeting and voting process. There is no financial data or report content, only the official announcement of voting results from the shareholders' meeting. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, not a full report or presentation.
2024-01-02 Chinese
关于召开公司2024年第一次临时股东大会的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement about the convening of the 2024 first extraordinary general meeting (临时股东大会) of shareholders for 中粮生物科技股份有限公司. It includes information on the meeting date, voting procedures (both in-person and online), agenda items to be voted on, registration methods, and proxy voting instructions. There is no financial data, earnings information, or audit content. The document is not a report itself but an announcement and instructions related to a shareholders meeting. It is not a voting results declaration since it does not provide results, only the notice and procedural details. Therefore, the document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about the meeting and voting process, not the meeting materials or results themselves.
2023-12-22 Chinese
关于调整公司2023年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 中粮生物科技股份有限公司 regarding adjustments to the company's 2023 daily related-party transactions forecast. It includes detailed information about the nature, amounts, and counterparties of these related-party transactions, as well as approvals by the board and independent directors. The document is a formal disclosure of changes in related-party transactions, which is a regulatory announcement typically required by stock exchanges to inform shareholders and the market about significant related-party dealings. It does not contain financial statements, audit opinions, or detailed financial results, nor is it a report like an annual or interim report. It is also not a voting result, management change, or legal proceeding. Given the content and context, this fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2023-12-15 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.